Running of high patient volume radiation oncology department during COVID-19 crisis in India: our institutional strategy

다국어 초록 (Multilingual Abstract)

Purpose: Due to COVID 19 pandemic, the treatment of cancer patients has become a dilemma for every oncologist. Cancer patients are at an increased risk of immunosuppression and have a higher risk to acquire any infection. There are individual experiences from some centers regarding the management of cancer patients during such a crisis. So we have developed our institutional strategy to balance between COVID and cancer management. Materials and Methods: Radiation Oncology departmental meeting was held to prepare a consensus document on Radiotherapy schedules and department functioning during this pandemic. Results: Strategies were taken in form of following areas were steps need to be taken to decrease risk of infection, categorise treatment on the basis of priority, radiotherapy schedules modification, academic meetings and management of COVID positive patient/personnel in Radiation Oncology department. Conclusion: We hope to strike the balance in overcoming both the battles and emerge as winners. Stringent long term follow up will be done for assessing the response or any unforeseen treatment related sequelae.

목차 (Table of Contents)

• Introduction Materials and Methods Results Discussion and Conclusion Conflict of Interest References

참고문헌 (Reference)

1 World Health Organization, "Statement on the meeting of the International Health Regulations (2005) Emergency Committee re1. World Health Organization. Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)" World Health Organization

2 de Wit E, "SARS and MERS : recent insights into emerging coronaviruses" 14 : 523-534, 2016

3 World Health Organization, "Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)" World Health Organization

4 Zhao S, "Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak" 92 : 214-217, 2020

5 Cui J, "Origin and evolution of pathogenic coronaviruses" 17 : 181-192, 2019

6 World Health Organization, "Novel Coronavirus – China" World Health Organization

7 World Health Organization, "Key considerations for repatriation and quarantine of travellers in relation to the outbreak of novel coronavirus 2019-nCoV" World Health Organization

8 Ferlay J, "Estimating the global cancer incidence and mortality in 2018 : GLOBOCAN sources and methods" 144 : 1941-1953, 2019

9 Centers for Disease Control and Prevention, "Coronavirus disease 2019 (COVID-19) situation summary" Centers for Disease Control and Prevention

10 Liang W, "Cancer patients in SARS-CoV-2 infection : a nationwide analysis in China" 21 : 335-337, 2020

11 Perlman S, "Another decade, another Coronavirus" 382 : 760-762, 2020

12 Wang C, "A novel coronavirus outbreak of global health concern" 395 : 470-473, 2020